HRT: ຄວາມຈິງທີ່ແພດອາຈຈະບໍ່ເວົ້າໃຫ້ເຈົ້າ

ສິ່ງທີ່ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ.

ສິ່ງທີ່ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ.

ສິ່ງທີ່ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ.

ສິ່ງທີ່ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ ສຽງສິດສະຖານທີ່ສູງກວ່າ 60 ປີ.

Many women find that raising the topic of HRT with their doctor is frustrating — some doctors are still influenced by outdated WHI-era fears, and others may not be trained in modern menopause management. Here's how to advocate for yourself effectively.

Come prepared with documentation. Track your symptoms for 2-4 weeks: type, severity, frequency, and impact on daily life. Rate them on a 1-10 scale. This transforms a vague "I'm not feeling well" into actionable clinical data.

Use specific language. Instead of "I think I might be in perimenopause," try: "I'm experiencing hot flashes 4-5 times daily, waking 3 times per night with drenching sweats, and my mood symptoms are affecting my work and relationships. I'd like to discuss whether hormone therapy is appropriate for me."

Know the guidelines. NAMS, the Endocrine Society, and the British Menopause Society all state that for symptomatic women under 60 without contraindications, hormone therapy is first-line treatment. If your doctor dismisses HRT categorically, ask them to cite their source — because current evidence-based guidelines support it.

If your doctor is not knowledgeable about or willing to prescribe HRT, you have options. The NAMS website (menopause.org) has a "Find a Menopause Practitioner" directory. Many telehealth services now specialize in menopause care. You deserve a provider who is current on the evidence.

While HRT is appropriate for most symptomatic perimenopausal and early postmenopausal women, there are genuine contraindications. Current or recent hormone-sensitive breast cancer is the most significant — estrogen can fuel the growth of estrogen-receptor-positive breast cancers. Women with a history of breast cancer should discuss alternatives with their oncologist.

Active or recent blood clots (deep vein thrombosis or pulmonary embolism) are a contraindication for oral estrogen, though transdermal estrogen may be considered in some cases under specialist supervision. Active liver disease, unexplained vaginal bleeding (which needs investigation first), and certain types of stroke or heart disease may also preclude HRT.

A family history of breast cancer alone is not an automatic contraindication — this is a common misconception. The absolute risk increase from HRT is small, and for many women with a family history, the benefits still outweigh the risks. However, these decisions should be individualized with a knowledgeable provider who can assess your complete risk profile.

For women who cannot or choose not to use hormonal therapy, effective non-hormonal options exist for many symptoms: SSRIs/SNRIs for mood and hot flashes, gabapentin for hot flashes, vaginal moisturizers and low-dose vaginal estrogen (which has minimal systemic absorption) for vaginal symptoms, and cognitive behavioral therapy for mood and sleep.